企業プロフィール
Connect Biopharma Holdings Limited 株価・ニュース・カタリスト
- ティッカー:
- CNTB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- China and listed in the U
株価パフォーマンス
2.49 USD (-2.35%)
終値
最終更新: 2026年8月17日
135M USD
時価総額
株価変動の要因
As of Aug 17, 2026, CNTB closed down 2.35% at $2.49. No new same-company headline was identified in the current news window.
企業概要
事業概要
Connect Biopharma is an immunology company focused on inflammatory and autoimmune diseases. Its story is built around developing targeted therapies for chronic immune-mediated conditions.
所在地とセクター分類
Connect Biopharma is headquartered in China and listed in the U.S. market. It sits in specialty immunology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, translational confidence, and the ability to progress a focused inflammatory pipeline. Investors watch efficacy signals and strategic developments.
バイオ業界での位置付け
Connect occupies a niche immunology position within biotech. It is catalyst-sensitive because the market needs evidence that the platform can differentiate in a crowded area.
今後のカタリスト
- Connect Biopharma’s catalysts are its inflammatory-disease programs, especially any update that clarifies whether the company can still build a credible immunology story. The market will care about human data.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。